These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 22016508)

  • 1. Chondrolectin is a novel diagnostic biomarker and a therapeutic target for lung cancer.
    Masuda K; Takano A; Oshita H; Akiyama H; Tsuchiya E; Kohno N; Nakamura Y; Daigo Y
    Clin Cancer Res; 2011 Dec; 17(24):7712-22. PubMed ID: 22016508
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of a cleavage stimulation factor, 3' pre-RNA, subunit 2, 64 kDa (CSTF2) as a therapeutic target for lung cancer.
    Aragaki M; Takahashi K; Akiyama H; Tsuchiya E; Kondo S; Nakamura Y; Daigo Y
    Clin Cancer Res; 2011 Sep; 17(18):5889-900. PubMed ID: 21813631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involvement of epithelial cell transforming sequence-2 oncoantigen in lung and esophageal cancer progression.
    Hirata D; Yamabuki T; Miki D; Ito T; Tsuchiya E; Fujita M; Hosokawa M; Chayama K; Nakamura Y; Daigo Y
    Clin Cancer Res; 2009 Jan; 15(1):256-66. PubMed ID: 19118053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ADAM8 as a novel serological and histochemical marker for lung cancer.
    Ishikawa N; Daigo Y; Yasui W; Inai K; Nishimura H; Tsuchiya E; Kohno N; Nakamura Y
    Clin Cancer Res; 2004 Dec; 10(24):8363-70. PubMed ID: 15623614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification and classification of differentially expressed genes in non-small cell lung cancer by expression profiling on a global human 59.620-element oligonucleotide array.
    Hofmann HS; Bartling B; Simm A; Murray R; Aziz N; Hansen G; Silber RE; Burdach S
    Oncol Rep; 2006 Sep; 16(3):587-95. PubMed ID: 16865260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of Pokemon in non-small cell lung cancer and foreshowing tumor biological behavior as well as clinical results.
    Zhao ZH; Wang SF; Yu L; Wang J; Chang H; Yan WL; Zhang J; Fu K
    Lung Cancer; 2008 Oct; 62(1):113-9. PubMed ID: 18550205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plakophilin 3 oncogene as prognostic marker and therapeutic target for lung cancer.
    Furukawa C; Daigo Y; Ishikawa N; Kato T; Ito T; Tsuchiya E; Sone S; Nakamura Y
    Cancer Res; 2005 Aug; 65(16):7102-10. PubMed ID: 16103059
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of pigment epithelial derived factor is reduced in non-small cell lung cancer and is linked to clinical outcome.
    Zhang L; Chen J; Ke Y; Mansel RE; Jiang WG
    Int J Mol Med; 2006 May; 17(5):937-44. PubMed ID: 16596284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced XPC messenger RNA level may predict a poor outcome of patients with nonsmall cell lung cancer.
    Wu YH; Cheng YW; Chang JT; Wu TC; Chen CY; Lee H
    Cancer; 2007 Jul; 110(1):215-23. PubMed ID: 17508409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical validity of the lung cancer biomarkers identified by bioinformatics analysis of public expression data.
    Kim B; Lee HJ; Choi HY; Shin Y; Nam S; Seo G; Son DS; Jo J; Kim J; Lee J; Kim J; Kim K; Lee S
    Cancer Res; 2007 Aug; 67(15):7431-8. PubMed ID: 17671213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer-testis antigen lymphocyte antigen 6 complex locus K is a serologic biomarker and a therapeutic target for lung and esophageal carcinomas.
    Ishikawa N; Takano A; Yasui W; Inai K; Nishimura H; Ito H; Miyagi Y; Nakayama H; Fujita M; Hosokawa M; Tsuchiya E; Kohno N; Nakamura Y; Daigo Y
    Cancer Res; 2007 Dec; 67(24):11601-11. PubMed ID: 18089789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of KIF4A as a prognostic biomarker and therapeutic target for lung cancer.
    Taniwaki M; Takano A; Ishikawa N; Yasui W; Inai K; Nishimura H; Tsuchiya E; Kohno N; Nakamura Y; Daigo Y
    Clin Cancer Res; 2007 Nov; 13(22 Pt 1):6624-31. PubMed ID: 18006763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic significance of serum miRNA-21 expression in human non-small cell lung cancer.
    Wang ZX; Bian HB; Wang JR; Cheng ZX; Wang KM; De W
    J Surg Oncol; 2011 Dec; 104(7):847-51. PubMed ID: 21721011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phosphorylation and activation of cell division cycle associated 5 by mitogen-activated protein kinase play a crucial role in human lung carcinogenesis.
    Nguyen MH; Koinuma J; Ueda K; Ito T; Tsuchiya E; Nakamura Y; Daigo Y
    Cancer Res; 2010 Jul; 70(13):5337-47. PubMed ID: 20551060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. L1 cell adhesion molecule promotes tumorigenicity and metastatic potential in non-small cell lung cancer.
    Hai J; Zhu CQ; Bandarchi B; Wang YH; Navab R; Shepherd FA; Jurisica I; Tsao MS
    Clin Cancer Res; 2012 Apr; 18(7):1914-24. PubMed ID: 22307136
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined use of oligonucleotide and tissue microarrays identifies cancer/testis antigens as biomarkers in lung carcinoma.
    Sugita M; Geraci M; Gao B; Powell RL; Hirsch FR; Johnson G; Lapadat R; Gabrielson E; Bremnes R; Bunn PA; Franklin WA
    Cancer Res; 2002 Jul; 62(14):3971-9. PubMed ID: 12124329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IGFBP-3 hypermethylation-derived deficiency mediates cisplatin resistance in non-small-cell lung cancer.
    Ibanez de Caceres I; Cortes-Sempere M; Moratilla C; Machado-Pinilla R; Rodriguez-Fanjul V; Manguán-García C; Cejas P; López-Ríos F; Paz-Ares L; de CastroCarpeño J; Nistal M; Belda-Iniesta C; Perona R
    Oncogene; 2010 Mar; 29(11):1681-90. PubMed ID: 20023704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biomarker discovery in non-small cell lung cancer: integrating gene expression profiling, meta-analysis, and tissue microarray validation.
    Botling J; Edlund K; Lohr M; Hellwig B; Holmberg L; Lambe M; Berglund A; Ekman S; Bergqvist M; Pontén F; König A; Fernandes O; Karlsson M; Helenius G; Karlsson C; Rahnenführer J; Hengstler JG; Micke P
    Clin Cancer Res; 2013 Jan; 19(1):194-204. PubMed ID: 23032747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ANLN plays a critical role in human lung carcinogenesis through the activation of RHOA and by involvement in the phosphoinositide 3-kinase/AKT pathway.
    Suzuki C; Daigo Y; Ishikawa N; Kato T; Hayama S; Ito T; Tsuchiya E; Nakamura Y
    Cancer Res; 2005 Dec; 65(24):11314-25. PubMed ID: 16357138
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic assay based on hsa-miR-205 expression distinguishes squamous from nonsquamous non-small-cell lung carcinoma.
    Lebanony D; Benjamin H; Gilad S; Ezagouri M; Dov A; Ashkenazi K; Gefen N; Izraeli S; Rechavi G; Pass H; Nonaka D; Li J; Spector Y; Rosenfeld N; Chajut A; Cohen D; Aharonov R; Mansukhani M
    J Clin Oncol; 2009 Apr; 27(12):2030-7. PubMed ID: 19273703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.